Accueil / Tag Archives: California

Tag Archives: California

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy

Monday, March 20th 2017 at 2:00pm UTC First study of a liquid biopsy to predict response to immunotherapy Highly accurate with a PPV of 92% and 100% for progression after one and two cycles respectively Early discovery of treatment-induced hyper-progressive disease Published in the peer-reviewed journal, Clinical Cancer Research SAN …

Plus »

Dow Chairman and CEO Liveris to Receive STEM Leadership Hall of Fame Award from U.S. News & World Report

Tuesday, March 21st 2017 at 3:45pm UTC MIDLAND, Mich.–(BUSINESS WIRE)– The Dow Chemical Company (NYSE: DOW) announced today that Andrew Liveris, Dow’s chairman and CEO, will receive the U.S. News Science, Technology, Engineering and Math (STEM) Leadership Hall of Fame Award at the publication’s upcoming STEM Solutions National Leadership Conference …

Plus »

New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease

Tuesday, March 21st 2017 at 12:00pm UTC CarrierScan™ Assay from Thermo Fisher Scientific consolidates conventional multi-assay approach for “all-in-one” research CARLSBAD, Calif. & PHOENIX–(BUSINESS WIRE)– A new high-throughput, microarray-based assay designed to detect more than 6,000 genomic variations associated with inherited disease now provides molecular genetics laboratories with a consolidated …

Plus »

NantKwest Announces FDA Grant of Orphan Drug Designation for the Company’s aNK Natural Killer Cell Therapy in Merkel Cell Carcinoma

Monday, March 20th 2017 at 11:00am UTC CULVER CITY, Calif.–(BUSINESS WIRE)– NantKwest, Inc. (Nasdaq:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases, announced today that the FDA has …

Plus »

Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics for the Treatment of Cancer and Other Diseases

Monday, March 20th 2017 at 10:59am UTC Builds upon initial 2014 alliance in oncology Includes up to eight additional targets in oncology and other therapeutic areas CytomX to receive $200 million upfront payment NEW YORK & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and CytomX Therapeutics, Inc. (Nasdaq:CTMX), …

Plus »

Endocrine Disrupting Chemicals Identified Using xCELLigence® Real-Time Cell Analysis

Monday, March 20th 2017 at 9:00am UTC ACEA Biosciences develops novel assay for the rapid and facile detection of agonists and antagonists of key endocrine receptors SAN DIEGO–(BUSINESS WIRE)– Endocrine-disrupting chemicals (EDCs) are substances that interfere with the ability of endogenous hormones to regulate homeostasis via their cognate nuclear receptors. …

Plus »

REVOLUTION Medicines Appoints Cancer Leader Dr. Stephen Kelsey as President of Research and Development

Monday, March 20th 2017 at 2:00pm UTC REDWOOD CITY, Calif.–(BUSINESS WIRE)– REVOLUTION Medicines, Inc., a company focused on frontier cancer targets and drug discovery inspired by nature’s lessons, today announced the appointment of Stephen (Steve) Kelsey, M.D., an accomplished physician-scientist, oncologist and cancer drug developer, as president of research and …

Plus »

Agilent Technologies Enhances Exome Sequencing for Clinical Research

Tuesday, March 21st 2017 at 3:00pm UTC New Target Enrichment Product Delivers Deep Coverage of Disease Relevant Content SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease …

Plus »

Nucleus Biologics Announces Highest Levels of Fetal Bovine Serum Testing in Industry to “Re-Define” Serum

Monday, March 20th 2017 at 8:45pm UTC Nucleus Biologics surpasses industry standards with 78 tests performed to further characterize FBS, helping scientists make best serum choices for their experiments SAN DIEGO–(BUSINESS WIRE)– Nucleus Biologics, a cell culture products supplier to the biotech and pharmaceutical industries, is announcing it is increasing …

Plus »

Global Venture Firm NEA Joins SetPoint Medical Syndicate of Investors

Monday, March 20th 2017 at 12:00pm UTC – NEA General Partner Josh Makower, MD Added to SetPoint Board of Directors – VALENCIA, Calif.–(BUSINESS WIRE)– SetPoint Medical, a biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced that global venture capital firm New Enterprise Associates, Inc. (NEA) has …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...